Table 4.
Inhibition zone diameters (IZDs) of the tested compounds against reference bacterial strains.
| Bacterial reference strain | IZD (mm) | |||
|---|---|---|---|---|
| C. vulgaris | SeNPs | CV-SeNPs | Gentamicin | |
| E. faecalis (ATCC 29212) | 18 ± 0.6 | 16 ± 0.6 | 20 ± 0.6ab | 30 ± 0.6abc |
| S. aureus (ATCC 25923) | 16 ± 0.6 | 11 ± 0.6a | 16 ± 0.6b | 28 ± 0.6abc |
| E. coli (ATCC 25922) | 11 ± 0.6 | 10 ± 0.0 | 11 ± 0.6 | 26 ± 1abc |
| K. pneumoniae (ATCC 700603) | 10 ± 0.0 | 10 ± 0.0 | 10 ± 0.0 | 22 ± 1abc |
| P. aeruginosa (ATCC 27853) | 10 ± 0.6 | 10 ± 0.6 | 10 ± 0.0 | 21 ± 0.6abc |
| P. mirabilis (ATCC 35659) | 12 ± 0.6 | 10 ± 0.0a | 12 ± 0.6b | 24 ± 0.6abc |
Data were recorded as mean ± SD (n = 3). aSignificant vs. C. vulgaris group, bSignificant vs. SeNPs group, and cSignificant vs. CV-SeNPs group. Each group differed significantly from the others at p < 0.05.